Target Price | $6.50 |
Price | $0.36 |
Potential |
1,695.58%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Onconova Therapeutics Inc. 2025 .
The average Onconova Therapeutics Inc. target price is $6.50.
This is
1,695.58%
register free of charge
$7.00
1,833.70%
register free of charge
$6.00
1,557.46%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Onconova Therapeutics Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Onconova Therapeutics Inc. stock has an average upside potential 2025 of
1,695.58%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.23 | 0.23 |
0.00% | 0.87% | |
Net Margin | -9,903.91% | -63,275.00% |
1.10% | 538.89% |
2 Analysts have issued a sales forecast Onconova Therapeutics Inc. 2024 . The average Onconova Therapeutics Inc. sales estimate is
This results in the following potential growth metrics:
2 Onconova Therapeutics Inc. Analysts have issued a net profit forecast 2024. The average Onconova Therapeutics Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.90 | -5.70 |
1.10% | 533.33% | |
P/E | negative | |
EV/Sales | 455.66 |
2 Analysts have issued a Onconova Therapeutics Inc. forecast for earnings per share. The average Onconova Therapeutics Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Onconova Therapeutics Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Onconova Therapeutics Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.